IP Library Granted Patent US 11,517,338
Granted Patent B2
US 11,517,338 · App. 16/569,303 · Granted Dec 6, 2022

Drug delivery shock wave balloon catheter system

Inventor: Daniel Hawkins (Santa Clara, CA)
Assignee: SHOCKWAVE MEDICAL, INC.
A61B17/2202A61K41/0028A61K47/6957A61L29/16A61M25/104A61B2017/003A61B2017/00703A61B2017/22021A61B2017/22024A61B2017/22025A61B2017/22061A61B2017/22062A61B2017/22084A61B2017/22088A61L2300/622A61M37/0092A61M2025/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,517,338
App. No.
16/569,303
Granted
Dec 6, 2022
Kind
B2
Abstract

A catheter comprises an elongated carrier and a balloon carried by the carrier in sealed relation thereto. The balloon has an outer surface and is arranged to receive a fluid therein that inflates the balloon. The catheter further comprises a shock wave generator within the balloon that forms mechanical shock waves within the balloon, and a medicinal agent carried on the outer surface of the balloon. The medicinal agent is releasable from the balloon either before or in response to the shock wave.

Claims (12)

1. A method for treating calcified lesions in a blood vessel comprising:

providing a catheter having an elongated carrier, a balloon carried by the elongated carrier in sealed relation thereto, a shock wave generator within the balloon, and a medicinal agent applied to the outer surface of the balloon in a manner such that the medicinal agent is at least partially released when the balloon is inflated into contact with the wall of a blood vessel;

inserting the catheter into a blood vessel to be treated;

inflating the balloon with a liquid to a pressure sufficient to create contact between the outer surface of the balloon and the wall of the blood vessel causing the release of a portion of the medicinal agent from the balloon without the generation of shock waves;

generating a shock wave within the balloon to crack calcified lesions in the blood vessel with the balloon remaining sealed both during and after the creation of the shock wave; and

after the generating step, further inflating the balloon with the liquid to further release the medicinal agent.

2. The method of claim 1 , wherein during the initial inflating step, the balloon is pressurized to between 1 and 4 atmospheres.

3. The method of claim 1 wherein the shock wave is generated by supplying a high voltage pulse to a pair of electrodes located within the balloon to produce a plasma arc which in turn creates a mechanical shock wave within the balloon.

4. The method of claim 1 wherein the medicinal agent is in the form of a drug coated on the outer surface of the balloon wall.

5. The method of claim 1 wherein the medicinal agent is coated on the outer surface of the balloon with an excipient.

6. The method of claim 1 , wherein the medicinal agent is contained within a plurality of microspheres.

7. The method of claim 1 , wherein the medicinal agent is a drug contained within a plurality of microcapsules, wherein the drug is releasable from the plurality of microcapsules in response to the shock wave.

Assignments (3)
TERMINATION OF PATENT SECURITY AGREEMENT Recorded Jun 3, 2024
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: SHOCKWAVE MEDICAL, INC.
Reel/Frame 067605/0799 →
SECURITY AGREEMENT Recorded Oct 20, 2022
From: SHOCKWAVE MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 061728/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2019
From: HAWKINS, DANIEL
To: SHOCKWAVE MEDICAL, INC.
Reel/Frame 050704/0405 →
Continuity (2)
Continuation 15491408 · Apr 19, 2017
Related Publication 20200000484A1 · Jan 2, 2020
Cited By (3)
US 12,396,742 US 12,402,901 US 12,453,565